In November 2015, BIOTRONIK announced that patients in European countries would now be able to benefit from the BioMonitor 2, a subcutaneous, insertable cardiac monitor. In August 2015, BIOTRONIK had announced CE approval and the results of a...
In November 2015, BIOTRONIK announced that patients in European countries would now be able to benefit from the BioMonitor 2, a subcutaneous, insertable cardiac monitor. In August 2015, BIOTRONIK had announced CE approval and the results of a...
In November 2015, BIOTRONIK...